Wednesday, July 2nd 2003, 12:00 am
By: News On 6
(Oklahoma City-AP) -- Consumers who may have been overcharged for a commonly prescribed cancer medication have until November 14th to seek restitution.
Oklahoma Attorney General Drew Edmondson and 49 other attorneys general reached a settlement with Bristol-Myers Squibb Company in April. Bristol-Myers must pay 55 million dollars in damages, penalties and consumer redress.
A total of 12.5 million dollars will go directly to consumers.
Edmondson says consumers who purchased Taxol between January 1999 and February 2003 may be eligible for restitution.
The states alleged Bristol-Myers fraudulently obtained patents for Taxol. That delayed generic versions of the breast and ovarian cancer drug from entering the market by at least 30 months.